Newborn Biotech has completed over 100 million yuan in Series C financing.

36Kr learned that "Newborn Biotech" recently announced the completion of over 100 million yuan in Series C financing. This round of financing was led by Mingxi Capital, followed by Optics Valley Industrial Investment, and old shareholders Yida Capital and Huaxi Yuanyou Fund continued to increase their investment. The financing funds will be mainly used for the construction of new technology platforms, capacity expansion, and the deepening of the global commercial layout.